Search results
Leukemia drug passes final trial phase with flying colors
Medical Xpress· 7 days agoPresenting the findings at the American Society of Clinical Oncology (ASCO 2024) Annual Meeting in...
SAP BrandVoice: Business Transformation: 4 Industry-Leading Companies Doing It Right
Forbes· 9 hours agoAt the recent SAP Sapphire event, four industry-leading companies joined SAP Executive Board Members...
The UN Cybercrime Draft Convention Remains Too Flawed to Adopt
Electronic Frontier Foundations· 4 days agoThe proposed UN Cybercrime Convention, scheduled for a critical concluding session from 29 July to...
Why Israeli relief over hostages’ rescue from Gaza was short-lived
The Christian Science Monitor· 17 hours agoIsraelis erupted in a spontaneous outpouring of joy Saturday as news broke over the dramatic rescue...
Chanel Needed a Change
The Cut· 4 days ago“Virginie is an inspiring woman very successfully creating for women everywhere, and the feedback of clients … it’s really positive,” Leena Nair,...
The Fed's next decision will likely mean Americans are going to wait a lot longer for any interest...
Business Insider· 4 hours agoThis story is available exclusively to Business Insider subscribers. Become an Insider and start...
AI-powered voice clarity startup Tomato.ai launches with $2.1M in seed funding - SiliconANGLE
SiliconANGLE· 58 minutes agoTomato.ai Inc., an artificial intelligence startup that’s using generative AI to improve voice communications, said today it has closed a $2.1 million seed funding round. The investment was ...
"The Acolyte" bait and switch angered some, but many more kept watching. That's why it works
Salon via Yahoo News· 3 days agoThe usual caveats about grains of salt apply. But as a point of comparison, that’s more than the 4...
US FDA grants accelerated approval to Genfit and Ipsen's liver disease drug
Reuters via AOL· 17 hours ago(Reuters) -The U.S. Food and Drug Administration granted accelerated approval to French drugmakers...
Skye Bioscience ends eye disease R&D efforts after glaucoma drug’s phase 2 fail
FierceBiotech· 1 day agoAs recently as April, Skye had been attributing its work getting SBI-100 into the phase 2...